Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause
Public ClinicalTrials.gov record NCT00314964. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study Evaluating PD-0299685 for Treatment of Vasomotor Symptoms Associated With Menopause
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to determine if PD-0299685 is effective and safe in the treatment of vasomotor symptoms (hot flashes / flushes) associated with menopause.
Study identification
- NCT ID
- NCT00314964
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 527 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 70 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Jul 2007 (Actual)
- Last update posted
- Mar 16, 2011
2006 – 2007
United States locations
- U.S. sites
- 56
- U.S. states
- 24
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Phoenix | Arizona | 85015 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85032 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85704 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85741 | — |
| Pfizer Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Pfizer Investigational Site | Greenbrae | California | 94904 | — |
| Pfizer Investigational Site | San Diego | California | 92103 | — |
| Pfizer Investigational Site | San Diego | California | 92128 | — |
| Pfizer Investigational Site | New London | Connecticut | 06320 | — |
| Pfizer Investigational Site | Leesburg | Florida | 34748 | — |
| Pfizer Investigational Site | Longwood | Florida | 32779 | — |
| Pfizer Investigational Site | Tampa | Florida | 33606 | — |
| Pfizer Investigational Site | Tampa | Florida | 33614 | — |
| Pfizer Investigational Site | West Palm Beach | Florida | 33407 | — |
| Pfizer Investigational Site | Alanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Alpharetta | Georgia | 30005 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30034 | — |
| Pfizer Investigational Site | Stockbridge | Georgia | 30281 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60610 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46202 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46227 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46280 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21211 | — |
| Pfizer Investigational Site | North Dartmouth | Massachusetts | 02747 | — |
| Pfizer Investigational Site | Chaska | Minnesota | 55318 | — |
| Pfizer Investigational Site | Waconia | Minnesota | 55387 | — |
| Pfizer Investigational Site | Olive Branch | Mississippi | 38654 | — |
| Pfizer Investigational Site | Springfeild | Missouri | 65807 | — |
| Pfizer Investigational Site | Springfeild | Missouri | 65810 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68510 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68131 | — |
| Pfizer Investigational Site | Lebanon | New Hampshire | 03756 | — |
| Pfizer Investigational Site | Lawrenceville | New Jersey | 08648 | — |
| Pfizer Investigational Site | New Brunswick | New Jersey | 08901 | — |
| Pfizer Investigational Site | New Bern | North Carolina | 28562 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27609 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45219 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44122 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43213 | — |
| Pfizer Investigational Site | Sellersville | Pennsylvania | 18960 | — |
| Pfizer Investigational Site | Columbia | South Carolina | 29201 | — |
| Pfizer Investigational Site | Austin | Texas | 78705 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78212 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78258 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84109 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84121 | — |
| Pfizer Investigational Site | Arlington | Virginia | 22205 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23226 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23229 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
| Pfizer Investigational Site | Virginia Beach | Virginia | 23455 | — |
| Pfizer Investigational Site | Seattle | Washington | 98105 | — |
| Pfizer Investigational Site | Spokane | Washington | 99207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00314964, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2011 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00314964 live on ClinicalTrials.gov.